Dog
1,974 reported events
openFDA
Top reactions: Lack of efficacy - NOS (850) · Injection site swelling (688) · Wound (399) · Injection site pain (298) · Pain NOS (290)
United Kingdom — VMD
Stelfonta 1 mg/ml Solution for Injection for Dogs
Authorised animal medicine, recorded in United Kingdom — VMD. This is a neutral reference record and does not provide dosing or veterinary advice.
Reference information only — not veterinary advice and not a dosing source. Always consult a licensed veterinarian before giving any medicine to an animal.
Active substances
Target species
dogs
Authorisation
No. EU/2/19/248/001 · POM-V · Anti Neoplastic Agent
Source
United Kingdom — VMD. Original source.
Other Tigilanol Tiglate medicines
Reported adverse events (openFDA)
Spontaneous adverse-event reports that name Tigilanol Tiglate, by species — reported counts, not proven reactions.
Source: openFDA Animal & Veterinary adverse-event reports.
Surveillance reference only — these are spontaneous adverse-event report counts, not proven adverse reactions, not causation and not a measure of any product's risk or safety. Always consult a licensed veterinarian.